Cargando…

Profile of olanzapine long-acting injection for the maintenance treatment of adult patients with schizophrenia

Olanzapine long-acting injection (OLAI) is a crystalline salt composed of olanzapine and pamoic acid, which permits a depot intramuscular formulation of olanzapine. The half-life of olanzapine pamoate is 30 days, and its steady state is reached approximately at 12 weeks. Oral supplementation of olan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Lorenzo, Rosaria, Brogli, Alice
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2010
Materias:	Expert Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938306/ https://www.ncbi.nlm.nih.gov/pubmed/20856920 http://dx.doi.org/10.2147/NDT.S5463

Ejemplares similares

Long-acting injectable antipsychotics: focus on olanzapine pamoate
por: Lindenmayer, JP
Publicado: (2010)

The modern perspective for long-acting injectables antipsychotics in the patient-centered care of schizophrenia
por: Pietrini, Francesco, et al.
Publicado: (2019)

Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients
por: Maloney, Ann E, et al.
Publicado: (2010)

Long-acting risperidone injection: efficacy, safety, and cost-effectiveness of the first long-acting atypical antipsychotic
por: Chue, Pierre
Publicado: (2007)

Emerging treatments in the management of bipolar disorder – focus on risperidone long acting injection
por: El-Hage, Wissam, et al.
Publicado: (2010)

Risperidone long-acting injection: a review of its long term safety and efficacy
por: Rainer, Michael K
Publicado: (2008)

Once-monthly paliperidone injection for the treatment of schizophrenia
por: Bishara, Delia
Publicado: (2010)

Quetiapine in the treatment of schizophrenia and related disorders
por: Riedel, Michael, et al.
Publicado: (2007)

Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence
por: McIntyre, Roger S, et al.
Publicado: (2011)

The role of ziprasidone in adjunctive use with lithium or valproate in maintenance treatment of bipolar disorder
por: Bowden, Charles L
Publicado: (2011)

Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia
por: Bishop, Jeffrey R, et al.
Publicado: (2008)

A review of aripiprazole in the treatment of patients with schizophrenia or bipolar I disorder
por: Citrome, Leslie
Publicado: (2006)

Emerging role of sertindole in the management of schizophrenia
por: Cincotta, Stephanie L, et al.
Publicado: (2010)

Pharmacological treatment of negative symptoms in schizophrenia: update and proposal of a clinical algorithm
por: Cerveri, Giancarlo, et al.
Publicado: (2019)

Update on the management of symptoms in schizophrenia: focus on amisulpride
por: Mortimer, Ann M
Publicado: (2009)

Was the implementation strategy of the ProACT trial adequately proactive?
por: Mathioudakis, Alexander G., et al.
Publicado: (2019)

The management of schizophrenia: focus on extended-release quetiapine fumarate
por: Peuskens, Joseph
Publicado: (2011)

Expert Canadian consensus suggestions on the rational, clinical use of ziprasidone in the treatment of schizophrenia and related psychotic disorders
por: Kutcher, Stan, et al.
Publicado: (2005)

One21: A Novel, Customizable Injection Protocol for Treatment of the Forehead with IncobotulinumtoxinA
por: de Sanctis Pecora, Carla
Publicado: (2020)

Bilateral pulmonary nodules and acute respiratory failure in a 22-year-old man with dyspnoea and fever
por: Castellana, Giorgio, et al.
Publicado: (2017)

Direct and indirect effects of paliperidone extended-release tablets on negative symptoms of schizophrenia
por: Turkoz, Ibrahim, et al.
Publicado: (2008)

Biopsychology of Physical Activity in People with Schizophrenia: An Integrative Perspective on Barriers and Intervention Strategies
por: Arnautovska, Urska, et al.
Publicado: (2022)

Patient perspectives in the development and use of long-acting antipsychotics in schizophrenia: focus on olanzapine long-acting injection
por: Citrome, Leslie
Publicado: (2009)

Patient and Health Care Provider Perspectives on Long Acting Injectable Antipsychotics in Schizophrenia and the Introduction of Olanzapine Long-Acting Injection
por: Wehring, Heidi J., et al.
Publicado: (2011)

Olaparib and bevacizumab in front-line maintenance of ovarian cancer: an over reliance in unpowered subgroup analysis of the PAOLA-1 trial?
por: Paulino, Eduardo, et al.
Publicado: (2020)

Clinical profile of vigabatrin as monotherapy for treatment of infantile spasms
por: Lerner, Jason T, et al.
Publicado: (2010)

Initiation and maintenance of a Treat-and-Extend regimen for ranibizumab therapy in wet age-related macular degeneration: recommendations from the UK Retinal Outcomes Group
por: Amoaku, Winfried, et al.
Publicado: (2018)

Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection
por: Ascher-Svanum, Haya, et al.
Publicado: (2014)

Profile of ezogabine (retigabine) and its potential as an adjunctive treatment for patients with partial-onset seizures
por: Weisenberg, Judith LZ, et al.
Publicado: (2011)

Atomoxetine: a novel treatment for child and adult ADHD
por: Ledbetter, Marcialee
Publicado: (2006)

Long-term safety and effectiveness of zonisamide in the treatment of epilepsy: a review of the literature
por: Zaccara, Gaetano, et al.
Publicado: (2009)

Recommendations and Guidance for Steroid Injection Therapy and COVID-19 Vaccine Administration from the American Society of Pain and Neuroscience (ASPN)
por: Chakravarthy, Krishnan, et al.
Publicado: (2021)

Autoantibody Profiles in Autoimmune Rheumatic Diseases
por: Bizzaro, Nicola
Publicado: (2019)

Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer’s disease
por: Puangthong, Umamon, et al.
Publicado: (2009)

Expert Consensus on Injection Technique and Area-Specific Recommendations for the Hyaluronic Acid Dermal Filler VYC-12L to Treat Fine Cutaneous Lines
por: Ogilvie, Patricia, et al.
Publicado: (2020)

New and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and children
por: Domnitei, Diana, et al.
Publicado: (2010)

A study on blood pressure changes following Olanzapine Long Acting Injection (LAI) in schizophrenia
por: Gakkhar, Shivam, et al.
Publicado: (2022)

Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults
por: Howland, Robert H
Publicado: (2009)

Pharmacokinetics of olanzapine long-acting injection: the clinical perspective
por: Heres, Stephan, et al.
Publicado: (2014)

Novel therapies for severe asthma in children and adults
por: Delimpoura, Vasiliki, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tsj315rc0nvjkpq267ge6aq186